Live tape
Top 8, mentions 7d18,660GOOGL8,063 mentions▲ +0.02INTC1,914 mentions▲ +0.03AMZN1,775 mentions▲ +0.03MSFT1,746 mentions▲ +0.04RDDT1,427 mentions▲ +0.04NVDA1,352 mentions▲ +0.06META1,278 mentions▲ +0.02AAPL1,105 mentions▲ +0.07

Equity · Healthcare

CUE

NASDAQ

Cue Biopharma (CUE)

20.58 USD −3.81% vs prior close Oct 30, 2026
Cue Biopharma, Inc. price graph
63 sessions
40 10 4 Aug 30 Oct

The line runs 27 USD on 4 August through 20.58 USD on 30 October, on a scale from 10 to 40. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
149.5M USD
Revenue, year to Dec 2025
27.5M USD
EPS, diluted, year to Dec 2025
−0.28 USD
52-week range
5.31 USD – 38 USD
Avg volume
14.3K
Mentions, 30 days
64
Net sentiment
+0.05

as of Oct 30, 2026

Have Cue Biopharma (CUE) insiders bought or sold shares recently?

In the 90 days to 2 Nov 2026, Cue Biopharma insiders reported 7 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 30 Dec 2025.

Form 4, 90 days to 2 Nov 2026, newest reported trade 12 Oct 2026

Buys 0Sells 7Net sold $2.43MOther filings 3

Have Cue Biopharma (CUE) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
12 Oct 2026Ray SumitaChief Legal Compliance OfficerSell1,84452K USD
12 Oct 2026Lin Shao-LeeChief Executive OfficerSell11,087305K USD
12 Oct 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSell1,14432K USD
13 Aug 2026Lin Shao-LeeChief Executive OfficerSell18,258523K USD
13 Aug 2026Ray SumitaChief Legal Compliance OfficerSell8,829266K USD
13 Aug 2026Meluzio Michael VincentVP, Prin. Accounting OfficerSell5,628169K USD
12 Aug 2026Lin Shao-LeeChief Executive OfficerSell40,0001.1M USD
Sold7 open-market sales86,790$2.43M
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
ReportedInsiderTypeSharesValue
13 Aug 2026Ray SumitaChief Legal Compliance OfficerOption exercise18,196
13 Aug 2026Meluzio Michael VincentVP, Prin. Accounting OfficerOption exercise13,647
12 Aug 2026Lin Shao-LeeChief Executive OfficerOption exercise109,179

Which funds hold Cue Biopharma (CUE)?

2 of the 45 institutional funds we track reported a Cue Biopharma position for the quarter ended 30 Jun 2026 — a combined 1.3M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Cue Biopharma (CUE)?
FundPositionSharesValueShares q/q
Citadel AdvisorsNew position25,633809K USD
Renaissance TechnologiesNew position14,689464K USD
Renaissance TechnologiesExited

What has been filed or recorded for Cue Biopharma (CUE)?

The filings we hold for Cue Biopharma, newest first: 9 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Cue Biopharma (CUE)?
And
14 Oct 2026Fails to deliverShares failed to deliver10,410 shares204K USD notional · 0.143% of shares out
08 Oct 2026Fails to deliverShares failed to deliver4,653 shares105K USD notional · 0.064% of shares out
02 Oct 2026Fails to deliverShares failed to deliver930 shares23K USD notional · 0.013% of shares out
28 Sep 2026Fails to deliverShares failed to deliver210 shares7K USD notional · 0.003% of shares out
25 Sep 2026Fails to deliverShares failed to deliver16,197 shares532K USD notional · 0.223% of shares out
24 Sep 2026Fails to deliverShares failed to deliver2,229 shares71K USD notional · 0.031% of shares out
23 Sep 2026Fails to deliverShares failed to deliver107,024 shares3.3M USD notional · 1.473% of shares out
22 Sep 2026Fails to deliverShares failed to deliver72,935 shares2.1M USD notional · 1.004% of shares out
18 Sep 2026Fails to deliverShares failed to deliver2,924 shares111K USD notional · 0.040% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −24.14 USDRevenue $8M
30 Jun 2026FinancialsTotal assets30.7M USDat period end
30 Jun 2026FinancialsTotal equity2.3M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −1.08 USDRevenue $6M
31 Dec 2025Annual reportFY 2025 reportedEPS −0.28 USDRevenue $27M
31 Dec 2025FinancialsRevenue27.5M USDfiscal year
31 Dec 2025FinancialsNet income−26.6M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−0.28 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.07 USDRevenue $2M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −2.67 USDRevenue $3M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −4.95 USDRevenue $0M
31 Dec 2024Annual reportFY 2024 reportedEPS −0.72 USDRevenue $9M
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.17 USDRevenue $3M

What is Reddit saying about Cue Biopharma (CUE)?

Reddit mentioned CUE 64 times in the 30 days to 2 November 2026, across 7 of the communities we track. All of them were scored for sentiment: 56% read bullish, 9% bearish and 35% neither. Reddit data updated 2 November 2026.

30-day window, Method

Mentions, 30 days 64Bullish 56%Bearish 9%Communities 7Against the market +2 points

How do Reddit mentions of Cue Biopharma (CUE) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
64 mentions

Is the Reddit crowd more bullish on Cue Biopharma than on the market?

CUE reads 71% bullish, 18 points above the market (53%). Over 90 days the gap has run from -38 to +26 points.

CUE
71%
bullish, 2 Nov
Market
53%
bullish, all Reddit, 2 Nov
Gap
+18 pts
CUE against market
10%30%50%70%90%NovOctSep
10%30%50%70%90%NovOctSep

Where Cue Biopharma (CUE) is discussed

30 days

Where Cue Biopharma (CUE) is discussed
CommunityShareMentionsNet sentiment
r/wallstreetbets72%46+0.06
r/ausfinance11%7−0.06
r/options6%4+0.11
r/investing5%3+0.03
r/stocks3%2+0.03
r/commodities2%1+0.03
r/etfs2%1+0.15

Moves with Cue Biopharma (CUE)

co-mention r, 31 observations

Tickers whose daily Reddit volume rose and fell with Cue Biopharma (CUE)'s. Co-discussion, not price.

IR +0.61CHPS +0.56IBRX +0.55SI +0.55QCOM +0.53DB +0.53

How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method

The threads carrying the mentions

30 days, shown as posted

The threads carrying the mentions
ThreadCommunityMentionsLatest
Cutting losses based on options or technicalsby u/monkies77r/options24 weeks ago

Live discussion on Reddit, shown as posted. Titles link to the original threads.

Cue Biopharma (CUE): frequently asked questions

From live data
20.58

What did Cue Biopharma shares close at?

Cue Biopharma closed at 20.58 USD on 30 Oct 2026, down 3.81% on the close before. That is the end-of-day price from Finazon, not a live quote.

149.5M

What is Cue Biopharma’s market cap?

Cue Biopharma is worth 149.5M USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.

27.5M

What is Cue Biopharma’s revenue?

Cue Biopharma reported revenue of 27.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

7 sales

Have Cue Biopharma insiders bought or sold shares recently?

In the 90 days to 2 Nov 2026, Cue Biopharma insiders reported 7 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 30 Dec 2025. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

2 of 45

Which funds own Cue Biopharma?

2 of the 45 funds we track reported a Cue Biopharma position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Renaissance Technologies and Renaissance Technologies. See Funds

−24.14

When did Cue Biopharma last report earnings?

Cue Biopharma last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −24.14 USD; no next date is announced in SEC filings yet. See Filings

17 mentions

What is Reddit saying about Cue Biopharma?

Cue Biopharma was mentioned 17 times in the last 7 days across the finance subreddits we track, and 64 times over the trailing 30 days. Of the 64 mentions scored for sentiment, 56% read bullish and 9% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings